Outcomes and Predictors of Severe Community-acquired Pneumonia Among Adults Admitted to the University of Gondar Comprehensive Specialized Hospital: A Prospective Follow-up Study

Overview

Journal Infect Drug Resist

Publisher Dove Medical Press

Date 2023 Feb 6

PMID 36743334

Authors

Getasew Kassaw

Rezika Mohammed

Getahun Mengistu Tessema

Tesfaye Yesuf

Ayenew Molla Lakew

Gebrekidan Ewnetu Tarekegn

Affiliations

Soon will be listed here.

Abstract

Background: Severe community-acquired pneumonia is a common life-threatening infection with a high rate of unfavorable outcome. This study aimed to assess the outcomes and predictors of hospitalized severe community-acquired pneumonia patients at University of Gondar comprehensive specialized hospital.

Methods: A prospective follow-up study was conducted at University of Gondar comprehensive specialized hospital from May 1 to September 31, 2021. The data was collected by reviewing patients' charts and interviewing the patients themselves. Descriptive statistics, binary and multivariable logistic regression analysis were performed accordingly. Variables with -value <0.2 on binary logistic regression were analyzed using multivariable logistic regression and variables with <0.05 were considered to have significant association.

Results: A total of 239 admitted patients with severe community-acquired pneumonia were enrolled in the study. An unfavorable outcome was observed in 105 (44%) patients; 24.27% was in-hospital all-cause mortality, 12.5% was nonresolution, 5.8% was complicated cases, and 1.26% were gone against medical care for poor prognosis. After analyzing multivariable logistic regression, confusion (OR= 4.84; 95%CI: 1.47-15.88), anemia (OR= 2.36; 95%CI: 1.01-5.52), leukopenia (OR=4.38; 95%CI: 1.26-15.25), leukocytosis (OR=3.15; 95%CI: 1.23-7.96), elevated creatinine (OR=5.67; 95%CI: 1.72-18.65), intubation (OR=7.27; 95%CI: 1.58-33.37) and antibiotic revision during treatment for a different reason (OR=0.02; 95%CI: 0.01-0.07) were variables significantly associated with unfavorable outcome.

Conclusion: Unfavorable outcome was high among hospitalized severe community acquired pneumonia patients, and confusion, elevated creatinine, anemia, leukopenia, leukocytosis, intubation during admission, and antibiotic revision during the course were independent predictors associated significantly with the unfavorable outcome. It is important to consider the development of a treatment protocol for the hospital and to further research incorporating the microbiologic profile of the patients.

Citing Articles

Predictive value of plasma sB7-H3 and YKL-40 in pediatric refractory Mycoplasma pneumoniae pneumonia.

Zhao Q, Ji S, Jiang H, Lu D, Qian L, Zhang J Open Med (Wars). 2025; 20(1):20241114.

PMID: 39822987 PMC: 11737367. DOI: 10.1515/med-2024-1114.

Time to recovery from severe community-acquired pneumonia and its determinants among older adults admitted to North Wollo hospitals: A multi-centred cohort study.

Kitaw T, Azmeraw M, Temesgen D, Haile R J Glob Health. 2024; 14:04203.

PMID: 39325926 PMC: 11426932. DOI: 10.7189/jogh.14.04203.

References

Aston S, Rylance J . Community-Acquired Pneumonia in Sub-Saharan Africa. Semin Respir Crit Care Med. 2016; 37(6):855-867. DOI: 10.1055/s-0036-1592126. View

Ferreira-Coimbra J, Sarda C, Rello J . Burden of Community-Acquired Pneumonia and Unmet Clinical Needs. Adv Ther. 2020; 37(4):1302-1318. PMC: 7140754. DOI: 10.1007/s12325-020-01248-7. View

Balakrishnan I, Crook P, Morris R, Gillespie S . Early predictors of mortality in pneumococcal bacteraemia. J Infect. 2000; 40(3):256-61. DOI: 10.1053/jinf.2000.0653. View

Ewig S, Schafer H, Torres A . Severity assessment in community-acquired pneumonia. Eur Respir J. 2001; 16(6):1193-201. DOI: 10.1034/j.1399-3003.2000.16f27.x. View

Elshamly M, Nour M, Omar A . Clinical presentations and outcome of severe community-acquired pneumonia. Egypt J Chest Dis Tuberc. 2020; 65(4):831-839. PMC: 7125902. DOI: 10.1016/j.ejcdt.2016.06.002. View

Garcia-Vidal C, Fernandez-Sabe N, Carratala J, Diaz V, Verdaguer R, Dorca J . Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J. 2008; 32(3):733-9. DOI: 10.1183/09031936.00128107. View

Han X, Liu X, Chen L, Wang Y, Li H, Zhou F . Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients. BMC Infect Dis. 2020; 20(1):668. PMC: 7486582. DOI: 10.1186/s12879-020-05362-3. View

Xu L, Ying S, Hu J, Wang Y, Yang M, Ge T . Pneumonia in patients with cirrhosis: risk factors associated with mortality and predictive value of prognostic models. Respir Res. 2018; 19(1):242. PMC: 6280505. DOI: 10.1186/s12931-018-0934-5. View

Shoar S, Musher D . Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia (Nathan). 2020; 12:11. PMC: 7533148. DOI: 10.1186/s41479-020-00074-3. View

10.

Iqbal N, Irfan M, Siddique F, Arshad V, Bin Sarwar Zubairi A . Factors predicting in-hospital mortality among patients admitted with community acquired pneumonia at a tertiary care hospital Karachi, Pakistan. Clin Respir J. 2019; 14(4):328-334. DOI: 10.1111/crj.13137. View

11.

Sirvent J, Carmen de la Torre M, Lorencio C, Tache A, Ferri C, Garcia-Gil J . Predictive factors of mortality in severe community-acquired pneumonia: a model with data on the first 24h of ICU admission. Med Intensiva. 2013; 37(5):308-15. DOI: 10.1016/j.medin.2013.03.003. View

12.

Ewig S, Welte T, Chastre J, Torres A . Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis. 2010; 10(4):279-87. DOI: 10.1016/S1473-3099(10)70032-3. View

13.

Ramirez J . Community-acquired pneumonia in adults. Prim Care. 2003; 30(1):155-71. DOI: 10.1016/s0095-4543(02)00076-3. View

14.

Isturiz R, Luna C, Ramirez J . Clinical and economic burden of pneumonia among adults in Latin America. Int J Infect Dis. 2010; 14(10):e852-6. DOI: 10.1016/j.ijid.2010.02.2262. View

15.

Ito A, Ishida T, Tokumasu H, Washio Y, Yamazaki A, Ito Y . Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort. BMC Pulm Med. 2017; 17(1):78. PMC: 5414343. DOI: 10.1186/s12890-017-0424-4. View

16.

Lanks C, Musani A, Hsia D . Community-acquired Pneumonia and Hospital-acquired Pneumonia. Med Clin North Am. 2019; 103(3):487-501. DOI: 10.1016/j.mcna.2018.12.008. View

17.

Bartlett J, Mundy L . Community-acquired pneumonia. N Engl J Med. 1995; 333(24):1618-24. DOI: 10.1056/NEJM199512143332408. View

18.

Reade M, Weissfeld L, Angus D, Kellum J, Milbrandt E . The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia. BMC Pulm Med. 2010; 10:15. PMC: 2848211. DOI: 10.1186/1471-2466-10-15. View

19.

Thomsen R, Kasatpibal N, Riis A, Norgaard M, Sorensen H . The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study. J Gen Intern Med. 2008; 23(9):1407-13. PMC: 2517996. DOI: 10.1007/s11606-008-0672-3. View

20.

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View